Area of research
Biomedical Engineering · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Cancer research, Magnetic resonance imaging, Lung cancer, Materials science, and In vivo.
Development and characterisation of [18F]TTDP, a novel T cell immunoglobulin and ITIM domain tracer, in humanised mice and non-human primates
Porous Molybdenum Nitride Nanosphere as Carrier-Free and Efficient Nitric Oxide Donor for Synergistic Nitric Oxide and Chemo/Sonodynamic Therapy
Controlled Release of Hydrogen‐Carrying Perfluorocarbons for Ischemia Myocardium‐Targeting <sup>19</sup>F MRI‐Guided Reperfusion Injury Therapy
Pulmonary delivery of nano‐particles for lung cancer diagnosis and therapy: Recent advances and future prospects
Glycerol-weighted chemical exchange saturation transfer nanoprobes allow 19F/1H dual-modality magnetic resonance imaging-guided cancer radiotherapy
Noninvasive Monitoring of Immunotherapy in Lung Cancer by Lymphocyte Activation Gene 3 PET Imaging of Tumor-Infiltrating Lymphocytes
Alveolar Macrophages-Mediated Translocation of Intratracheally Delivered Perfluorocarbon Nanoparticles to Achieve Lung Cancer <sup>19</sup>F-MR Imaging
c-Met-Targeting 19F MRI Nanoparticles with Ultralong Tumor Retention for Precisely Detecting Small or Ill-Defined Colorectal Liver Metastases
Effect of silk fibroin scaffold loaded with 17-β estradiol on the proliferation and differentiation of BMSCs
Pulmonary Delivery of Theranostic Nanoclusters for Lung Cancer Ferroptosis with Enhanced Chemodynamic/Radiation Synergistic Therapy
An Osimertinib-Perfluorocarbon Nanoemulsion with Excellent Targeted Therapeutic Efficacy in Non-small Cell Lung Cancer: Achieving Intratracheal and Intravenous Administration
Magnetic Resonance/Infrared Dual-Modal Imaging-Guided Synergistic Photothermal/Photodynamic Therapy Nanoplatform Based on Cu1.96S-Gd@FA for Precision Cancer Theranostics
Single low-dose INC280-loaded theranostic nanoparticles achieve multirooted delivery for MET-targeted primary and liver metastatic NSCLC
Correction: Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancer
Pathophysiological mechanisms of ALPPS: experimental model
Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy
NIR-Driven Intracellular Photocatalytic O<sub>2</sub> Evolution on Z-Scheme Ni<sub>3</sub>S<sub>2</sub>/Cu<sub>1.8</sub>S@HA for Hypoxic Tumor Therapy
Precise Cancer Anti-acid Therapy Monitoring Using pH-Sensitive MnO<sub>2</sub>@BSA Nanoparticles by Magnetic Resonance Imaging
Phototherapy and multimodal imaging of cancers based on perfluorocarbon nanomaterials
Molecular Imaging, How Close to Clinical Precision Medicine in Lung, Brain, Prostate and Breast Cancers
Abstract PR-03: Radiomics and AI-based treatment decision support for non-small cell lung cancer
Non-invasive decision support for NSCLC treatment using PET/CT radiomics
Synthesis of MoSe<sub>2</sub>/CoSe<sub>2</sub> Nanosheets for NIR‐Enhanced Chemodynamic Therapy via Synergistic In‐Situ H<sub>2</sub>O<sub>2</sub> Production and Activation
<p>Perfluorocarbons-Based <sup>19</sup>F Magnetic Resonance Imaging in Biomedicine</p>
<sup>23</sup>Na‐MRI as a Noninvasive Biomarker for Cancer Diagnosis and Prognosis
<p>Affibody-Modified Gd@C-Dots with Efficient Renal Clearance for Enhanced MRI of EGFR Expression in Non-Small-Cell Lung Cancer</p>
Long non-coding RNA LINC01116 regulated miR-744-5p/SCN1B axis to exacerbate lung squamous cell carcinoma
Novel anilino quinazoline-based EGFR tyrosine kinase inhibitors for treatment of non-small cell lung cancer
Update on the development of molecular imaging and nanomedicine in China: Optical imaging
Machine learning-based multiparametric MRI radiomics for predicting the aggressiveness of papillary thyroid carcinoma